2010
DOI: 10.1002/iub.300
|View full text |Cite
|
Sign up to set email alerts
|

Emerging roles of deubiquitinases in cancer‐associated pathways

Abstract: SummaryDeubiquitinases (DUBs) are emerging as important regulators of many pathways germane to cancer. They may regulate the stability of key oncogenes, exemplified by USP28 stabilisation of c-Myc. Alternatively they can negatively regulate ubiquitin-dependent signalling cascades such as the NF-jB activation pathway. We review the current literature that associates DUBs with cancer and discuss their suitability as drug targets of the future.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
161
0

Year Published

2010
2010
2023
2023

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 156 publications
(163 citation statements)
references
References 170 publications
(138 reference statements)
1
161
0
Order By: Relevance
“…These two kinases are normally ubiquitinated by K33 and K29 chains (42). STK11 cannot phosphorylate and activate them unless the ubiquitin chains are removed by the deubiquitinating enzyme Usp9x (43,44). Therefore, activities of both STK11 and Usp9x are necessary for activation of MARK4 and NUAK1.…”
Section: Resultsmentioning
confidence: 99%
“…These two kinases are normally ubiquitinated by K33 and K29 chains (42). STK11 cannot phosphorylate and activate them unless the ubiquitin chains are removed by the deubiquitinating enzyme Usp9x (43,44). Therefore, activities of both STK11 and Usp9x are necessary for activation of MARK4 and NUAK1.…”
Section: Resultsmentioning
confidence: 99%
“…115 CYLD is also involved in the regulation of other cellular processes, such as cell migration and spermatogenesis. 116 Though not a therapeutic target due to its tumor suppressor status, a better understanding of CYLD regulation may be of value in developing strategies to reactivate its expression, and/or lead to its use as a biomarker for prognostic or therapeutic use related to the activity of the NFκB pathway in various cancers.…”
Section: Cyldmentioning
confidence: 99%
“…A number of deubiquitinases are reported to play critical roles in diverse cellular and physiological functions such as cell signaling, histone modification and so on [35,36]. Abnormal deubiquitinase activity is closely related to tumor cell survival as these enzymes modulate TGF-β, Wnt and TNF signaling pathways [37]. Several small molecules that inhibit distinct deubiquitinases have been identified, and these small molecules would be useful tools for studying the molecular mechanisms underlying the actions of these deubiquitinases, in addition to their potential therapeutic applications [38,39].…”
Section: Introductionmentioning
confidence: 99%